Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Secondary hyperparathyroidism, unclassified elsewhere (E21.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction
Lower-limb osteitis fibrosa cystica (E21.006) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
Upper-limb osteitis fibrosa cystica (E21.005) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
Spinal osteitis fibrosa cystica (E21.004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Mandibular osteitis fibrosa cystica (E21.003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled
Generalized osteitis fibrosa cystica (E21.002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compile
Parathyroid hyperplasia (E21.001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Femoral osteitis fibrosa cystica (E21.000x007) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compile
Primary hyperparathyroidism (E21.000x005) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Primary hyperparathyroidism is autonomous PTH overproduction (adenoma/hyperplasia/carcinoma) causing hypercalcemia, bone resorption, nephrolithiasis; 'bones, stones, groans, psychic overtones'; treated by surgery.
内分泌科Hypoparathyroid cataract () is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Parathyroid tetany (E20.901) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Hypoparathyroidism with myopathy (E20.900x004) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compile
Hypoparathyroid hypocalcemic cataract (E20.900x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being co
Hypoparathyroidism (E20.900x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Hypoparathyroidism is low PTH causing hypocalcemia/hyperphosphatemia; causes: postsurgical, autoimmune, genetic; presents with tetany, paresthesia, Chvostek/Trousseau signs, cataracts; treat with calcium/calcitriol.
内分泌科Congenital hypoparathyroidism (E20.802) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Secondary hypoparathyroidism (E20.801) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Congenital hypoparathyroidism (E20.800x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Secondary hypoparathyroidism (E20.800x001) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|